Homeeditorial

editorial

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

August 28, 2026

Roche’s Vabysmo demonstrates sustained two-year results in a difficult-to-treat form of neovascular age-related macular degeneration (nAMD)

Roche’s Vabysmo demonstrates sustained two-year results in a difficult-to-treat form of neovascular age-related macular degeneration (nAMD)

August 28, 2026

Micware Group Reorganization Finalized

Micware Group Reorganization Finalized

August 27, 2026

Cygnus Metals Limited: Drilling Results Update

Cygnus Metals Limited: Drilling Results Update

August 27, 2026

Inflection Point Acquisition Corp. VIII Announces Pricing of $250 Million Initial Public Offering

Inflection Point Acquisition Corp. VIII Announces Pricing of $250 Million Initial Public Offering

August 27, 2026

HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

August 27, 2026

Brixton Metals Announces Closing Of Final Tranche Of Private Placement For Aggregate Gross Proceeds Of $9.1 Million

Brixton Metals Announces Closing Of Final Tranche Of Private Placement For Aggregate Gross Proceeds Of $9.1 Million

August 27, 2026

Updated Managing Director and CEO’s Remuneration

Updated Managing Director and CEO’s Remuneration

August 27, 2026

2026 Annual General Meeting – Key Dates

2026 Annual General Meeting – Key Dates

August 27, 2026

FY26 Financial Results Summary

FY26 Financial Results Summary

August 27, 2026

« 1 … 8 9 10 11 12 … 1,475 »